Evaluation and Management of Rectourethral Fistulas After Prostate Cancer Treatment

被引：2

作者：

Anderson K.M. ^{[1
]}

Gallegos M. ^{[2
]}

Higuchi T.T. ^{[1
]}

Flynn B.J. ^{[1
]}

机构：

[1] Division of Urology, University of Colorado Denver, Academic Office One Bldg, 12631 East 17th Ave., Box C319, room L15-5602, Aurora, 80045, CO

[2] Division of Urology, UNM School of Medicine, MSC 10 5610, University of New Mexico, Albuquerque, 87131, NM

来源：

Current Bladder Dysfunction Reports | 2015年 / 10卷 / 2期

关键词：

Prostate cancer; Rectal fistula; Rectourethral fistula; Urinary fistula;

D O I：

10.1007/s11884-015-0297-4

中图分类号：

学科分类号：

摘要：

Most men newly diagnosed with prostate cancer will undergo local treatment with prostatectomy, radiation, or tissue ablation. A small percentage of these men will develop a rectourethral fistula, a complicated disease that requires a multidisciplinary approach to management. Diagnosis is typically made with a careful history and physical exam with endoscopy and select imaging recommended in all patients. Fistulas resulting from prostatectomy, radiation, or tissue ablative technology are approached differently due to local tissue changes following therapy. Post-radiation and thermal ablation fistulas have a lower fistula closure rate due to the deleterious effect of the primary treatment on local tissue. It is imperative that the patient understands the complexity of treatment and sets reasonable goals for treatment. © 2015, Springer Science+Business Media New York.

引用

页码：132 / 137

页数：5

共 27 条

[1]

Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013, CA Cancer J Clin, 63, 1, pp. 11-30, (2013)

[2]

Mahmood U., Levy L.B., Nguyen P.L., Lee A.K., Kuban D.A., Hoffman K.E., Current clinical presentation and treatment of localized prostate cancer in the United States, J Urol, 192, 6, pp. 1650-1656, (2014)

[3]

Lefevre J.H., Bretagnol F., Maggiori L., Alves A., Ferron M., Panis Y., Operative results and quality of life after gracilis muscle transposition for recurrent rectovaginal fistula, Dis Colon Rectum, 52, 7, pp. 1290-1295, (2009)

[4]

Borchers H., Pinkawa M., Donner A., Wolter T.P., Pallua N., Eble M.J., Et al., Rectourethral fistula following LDR brachytherapy, Urol Int, 82, 3, pp. 365-366, (2009)

[5]

Mundy A.R., Andrich D.E., Posterior urethral complications of the treatment of prostate cancer, BJU Int, 110, 3, pp. 304-325, (2012)

[6]

Kimura M., Mouraviev V., Tsivian M., Mayes J.M., Satoh T., Polascik T.J., Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy, BJU Int, 105, 2, pp. 191-201, (2010)

[7]

Brandes S.B., Morey A.F., Advanced male urethral and genital reconstructive surgery, (2013)

[8]

Thomas C., Jones J., Jager W., Hampel C., Thuroff J.W., Gillitzer R., Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy, J Urol, 183, 2, pp. 608-612, (2010)

[9]

Nyam D.C., Pemberton J.H., Management of iatrogenic rectourethral fistula, Dis Colon Rectum, 42, 8, pp. 994-997, (1999)

[10]

Hadley D.A., Southwick A., Middleton R.G., York-Mason procedure for repair of recto-urinary fistulae: a 40-year experience, BJU Int, 109, 7, pp. 1095-1098, (2012)

← 1 2 3 →